<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BBA Clin</journal-id><journal-id journal-id-type="iso-abbrev">BBA Clin</journal-id><journal-title-group><journal-title>BBA Clinical</journal-title></journal-title-group><issn pub-type="epub">2214-6474</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26673554</article-id><article-id pub-id-type="pmc">4661527</article-id><article-id pub-id-type="publisher-id">S2214-6474(14)00033-6</article-id><article-id pub-id-type="doi">10.1016/j.bbacli.2014.11.007</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Regular consumption of black tea increases circulating kynurenine concentrations: A randomized controlled trial<sup><xref ref-type="fn" rid="d32e446">&#x02606;</xref></sup></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gostner</surname><given-names>J.M.</given-names></name><xref rid="af0020" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Becker</surname><given-names>K.</given-names></name><xref rid="af0025" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Croft</surname><given-names>K.D.</given-names></name><xref rid="af0010" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Woodman</surname><given-names>R.J.</given-names></name><xref rid="af0015" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Puddey</surname><given-names>I.B.</given-names></name><xref rid="af0010" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Fuchs</surname><given-names>D.</given-names></name><email>dietmar.fuchs@i-med.ac.at</email><xref rid="af0025" ref-type="aff">b</xref><xref rid="cr0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author"><name><surname>Hodgson</surname><given-names>J.M.</given-names></name><xref rid="af0010" ref-type="aff">c</xref></contrib></contrib-group><aff id="af0020"><label>a</label>Division of Medical Biochemistry, Medical University of Innsbruck, Austria</aff><aff id="af0025"><label>b</label>Division of Biological Chemistry, Medical University of Innsbruck, Austria</aff><aff id="af0010"><label>c</label>School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia</aff><aff id="af0015"><label>d</label>Flinders Centre for Epidemiology and Biostatistics, School of Medicine, Flinders University, Adelaide, South Australia, Australia</aff><author-notes><corresp id="cr0005"><label>&#x0204e;</label>Corresponding author at: Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innrain 80, 6020 Innsbruck, Austria. Tel.: +&#x000a0;43 512 9003 70350; fax: +&#x000a0;43 512 9003 73110. <email>dietmar.fuchs@i-med.ac.at</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>04</day><month>12</month><year>2014</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>04</day><month>12</month><year>2014</year></pub-date><volume>3</volume><fpage>31</fpage><lpage>35</lpage><history><date date-type="received"><day>3</day><month>10</month><year>2014</year></date><date date-type="rev-recd"><day>25</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 The Authors</copyright-statement><copyright-year>2014</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).</license-p></license></permissions><abstract><sec><title>Background</title><p>Circulating neopterin and the ratio of kynurenine to tryptophan (KYN/TRP) concentrations are biomarkers of immune activation that have been linked to cardiovascular and total mortality. Several <italic>in vitro</italic> studies indicated that tea flavonoids and other antioxidants can modulate tryptophan breakdown rates and neopterin production in immune cells. We aimed to assess the effects of regular black tea consumption on tryptophan and neopterin metabolisms <italic>in vivo</italic>.</p></sec><sec><title>Methods</title><p>Participants were healthy individuals, with no major illnesses and having normal to mildly elevated systolic blood pressure. They were randomly assigned to consume 3&#x000a0;cups/day of either powdered black tea solids (tea; n&#x000a0;=&#x000a0;45) or a flavonoid-free caffeine-matched beverage (control; n&#x000a0;=&#x000a0;49). Serum concentrations of tryptophan, kynurenine and neopterin were assessed at baseline and again at 3 and 6&#x000a0;months after daily ingestion of the respective beverage.</p></sec><sec><title>Results</title><p>Regular consumption of tea over 6&#x000a0;months, compared to control, did not significantly alter neopterin (<italic>p</italic>&#x000a0;=&#x000a0;0.13) or tryptophan (<italic>p</italic>&#x000a0;=&#x000a0;0.85) concentrations, but did result in significantly higher kynurenine (<italic>p</italic>&#x000a0;=&#x000a0;0.016) and KYN/TRP (<italic>p</italic>&#x000a0;=&#x000a0;0.012). Relative to the control group, in the tea group kynurenine and KYN/TRP increased during the treatment period by 0.28&#x000a0;&#x003bc;mol/L (95% CI: &#x02212;&#x000a0;0.04, 0.60) and 3.2&#x000a0;&#x003bc;mol/mmol (95% CI: &#x02212;&#x000a0;1.6, 8.0), respectively at 3&#x000a0;months, and by 0.48&#x000a0;&#x003bc;mol/L (95% CI: 0.16, 0.80) and 7.5&#x000a0;&#x003bc;mol/mmol (95% CI: 2.5, 12.5), respectively at 6&#x000a0;months.</p></sec><sec><title>Conclusions</title><p>Increased circulation of kynurenine and KYN/TRP following regular black tea consumption may indicate enhanced tryptophan breakdown, possibly due to immune activation-induced tryptophan degrading enzyme indoleamine 2,3-dioxygenase.</p></sec><sec><title>General significance</title><p>The influence of black tea consumption on biomarkers of immune system activation could relate to its general health benefits. Data suggests that the net effect strongly depends on the individual immune state, being stimulatory in healthy individuals, while acting more immune dampening in situations with an inflammatory background.</p></sec></abstract><abstract abstract-type="author-highlights"><title>Highlights</title><p><list list-type="simple"><list-item id="u0005"><label>&#x02022;</label><p>Regular black tea consumption can modulate immunobiochemical pathways.</p></list-item><list-item id="u0010"><label>&#x02022;</label><p>Black tea consumption increases serum levels of tryptophan breakdown product kynurenine.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>Black tea does not increase levels of immune activation marker neopterin.</p></list-item><list-item id="u0020"><label>&#x02022;</label><p>Net effects strongly depend on the individual immune state.</p></list-item></list></p></abstract><kwd-group><title>Keyword</title><kwd>Black tea</kwd><kwd>Cardiovascular health</kwd><kwd>Immune system</kwd><kwd>Kynurenine</kwd><kwd>Neopterin</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title>Introduction</title><p>Inflammation and immune activation play key roles in the pathogenesis of atherosclerosis <xref rid="bb0005" ref-type="bibr">[1]</xref>, <xref rid="bb0010" ref-type="bibr">[2]</xref>. This is reflected by an increase of inflammatory cells, such as activated macrophages, and high level production of pro-inflammatory cytokines in the atherosclerotic plaque. In the circulation, the inflammatory process manifests in elevated concentrations of pro-inflammatory biomarkers such as interleukin-6, C-reactive protein and serum amyloid A <xref rid="bb0005" ref-type="bibr">[1]</xref>, <xref rid="bb0010" ref-type="bibr">[2]</xref>. Likewise, the macrophage product neopterin is formed and enhanced tryptophan breakdown is detectable by an increased kynurenine to tryptophan ratio (KYN/TRP) <xref rid="bb0015" ref-type="bibr">[3]</xref>, <xref rid="bb0020" ref-type="bibr">[4]</xref>. Both neopterin production and tryptophan breakdown are related to inflammation where increased formation of Th1-type cytokine interferon-&#x003b3; (IFN-&#x003b3;) activates neopterin production via GTP-cyclohydrolase I and induces tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Many inflammation-induced biomarkers have been found to strongly predict disease specific outcome and overall mortality in patients suffering from cardiovascular disease (CVD). Neopterin production and tryptophan breakdown may be among the most sensitive predictors of prognosis in such patients <xref rid="bb0020" ref-type="bibr">[4]</xref>.</p><p>Markers of antioxidant status such as vitamin C and E, as well as compounds like lycopene and lutein are reduced in patients suffering from inflammatory conditions such as CVD <xref rid="bb0025" ref-type="bibr">[5]</xref>, <xref rid="bb0030" ref-type="bibr">[6]</xref>. Moreover, there is evidence for a relationship between a higher degree of inflammation and immune activation and a lower vitamin status <xref rid="bb0035" ref-type="bibr">[7]</xref>. Dietary interventions are thought to be of value to slow-down inflammation. A diet rich in antioxidants and antioxidant supplements may provide benefit on cardiovascular outcomes <xref rid="bb0040" ref-type="bibr">[8]</xref>, <xref rid="bb0045" ref-type="bibr">[9]</xref>. In addition, a positive influence of Mediterranean diet supplemented with extra-virgin olive oil or nuts was demonstrated among persons at high cardiovascular risk <xref rid="bb0050" ref-type="bibr">[10]</xref>. A 2-year intervention trial involving healthy dietary changes had long-lasting, favorable post-intervention effects, particularly among participants receiving the Mediterranean and low-carbohydrate diets <xref rid="bb0055" ref-type="bibr">[11]</xref>. However, any positive influence of pure supplemented antioxidants like vitamins still remains to be demonstrated.</p><p>There is increasing evidence that beverages rich in antioxidant polyphenols like tea, cacao and red wine, could provide a positive influence on cardiovascular health. We recently reported that black tea can affect blood pressure beneficially <xref rid="bb0060" ref-type="bibr">[12]</xref>, <xref rid="bb0065" ref-type="bibr">[13]</xref>. Interestingly, antioxidant compounds and extracts of antioxidant-rich beverages such as tea were observed to suppress immune activation cascades, pro-inflammatory cytokines, neopterin and tryptophan breakdown in mitogen-stimulated human peripheral blood mononuclear cells (PBMC) in vitro <xref rid="bb0070" ref-type="bibr">[14]</xref>. These effects appear to be shared with other compounds and extracts prepared from plants and fruits with suggested anti-inflammatory and/or antioxidant properties like salicylic acid <xref rid="bb0070" ref-type="bibr">[14]</xref>, resveratrol <xref rid="bb0075" ref-type="bibr">[15]</xref> and cannabinoids <xref rid="bb0070" ref-type="bibr">[14]</xref>, black tea <xref rid="bb0080" ref-type="bibr">[16]</xref>, wine <xref rid="bb0085" ref-type="bibr">[17]</xref>, cacao <xref rid="bb0070" ref-type="bibr">[14]</xref> and coffee <xref rid="bb0090" ref-type="bibr">[18]</xref>. For the effect of black tea, flavonoid compounds are considered to be of importance <xref rid="bb0065" ref-type="bibr">[13]</xref>, <xref rid="bb0075" ref-type="bibr">[15]</xref>, <xref rid="bb0095" ref-type="bibr">[19]</xref>. However, in resting immune cells, the effects of compounds like resveratrol or beverages like wine or tea were found to be stimulatory rather than immunosuppressive <xref rid="bb0060" ref-type="bibr">[12]</xref>, <xref rid="bb0065" ref-type="bibr">[13]</xref>. Thus, results from <italic>in vitro</italic> studies only provide a limited picture.</p><p>We have previously reported the results from the primary outcome of the present study demonstrating that regular ingestion of black tea results in lower blood pressure and lower blood pressure variation <xref rid="bb0065" ref-type="bibr">[13]</xref>. Recently, kynurenine was shown to mediate vasorelaxation and lower blood pressure <xref rid="bb0095" ref-type="bibr">[19]</xref>. Thus, the objective of the current analysis was to assess the effects of longer-term regular consumption of black tea, over 6&#x000a0;months, on neopterin formation and tryptophan metabolism in healthy individuals with mild to moderate elevations in systolic blood pressure. We have also explored the relationships of any change in kynurenine concentrations with observed changes in blood pressure.</p></sec><sec id="s0010"><label>2</label><title>Subjects and methods</title><sec id="s0015"><label>2.1</label><title>Study subjects</title><p>Volunteers were recruited from the general population of Perth, Australia, by using print media advertisements. Participants were tea drinkers, aged 35&#x02013;75&#x000a0;years, had BMI of 19&#x02013;35&#x000a0;kg/m<sup>2</sup>, were non-diabetic, had not taken nutritional supplements or antibiotics from 4&#x000a0;weeks before beginning the trial, and had no major illness <xref rid="bb0065" ref-type="bibr">[13]</xref>. The trial was approved by the University of Western Australia Ethics Committee and registered at the Australian New Zealand Clinical trials Registry as ACTR12607000543482. Procedures followed were in accordance with institutional guidelines.</p></sec><sec id="s0020"><label>2.2</label><title>Study design</title><p>A randomized, controlled, double-blind, 6-month parallel-designed intervention study was performed <xref rid="bb0065" ref-type="bibr">[13]</xref>. The 6-month intervention was preceded by a 4-week run-in period during which participants consumed 3 cups of regular leaf tea each day prepared in the usual manner. During the fourth week of the run-in period, participants attended the School of Medicine and Pharmacology research unit located at Royal Perth Hospital, where all baseline measurements were performed. During the 6-month intervention period, participants consumed 3&#x000a0;cups/day of either powdered black tea solids, which supplied 429&#x000a0;mg&#x000a0;total&#x000a0;polyphenols&#x000a0;(primarily flavonoids)/day and 96&#x000a0;mg&#x000a0;caffeine&#x000a0;(tea)/day or a flavor-matched, flavonoid-free, and caffeine-matched placebo (control). Participants were advised to consume tea or control products at the time that they would normally consume tea. For further details see ref. <xref rid="bb0065" ref-type="bibr">[13]</xref>.</p><p>After random assignment, participants were required to follow a low-flavonoid diet throughout the trial. Apart from the prescribed tea intake, participants did not consume any additional tea, they did not consume dark chocolate or red wine, the intake of fruit juices was limited to &#x0003c;&#x000a0;4&#x000a0;glasses/week, and coffee intake was limited to &#x0003c;&#x000a0;1&#x000a0;cup/day on average (&#x0003c;&#x000a0;7&#x000a0;cups/week). A dietitian monitored each participant's progress every 4&#x000a0;weeks to ensure compliance. Participants were instructed to add the contents of a sachet of powdered tea solids or placebo to ~&#x000a0;200&#x000a0;mL boiled hot water and stir the solution until the powder completely dissolved. The addition of sugar, milk, cream or other additives was not allowed, and the product was consumed while still hot.</p></sec><sec id="s0025"><label>2.3</label><title>Laboratory measurements and blood pressure assessment</title><p>The 24&#x000a0;h 4-O-methylgallic acid (4OMGA) excretion was used as a biomarker of black tea intake and black tea-derived flavonoid exposure and to assess compliance <xref rid="bb0065" ref-type="bibr">[13]</xref>. To monitor immune activation status of study participants, free serum concentrations of tryptophan and kynurenine were determined by high-performance liquid chromatography, as described elsewhere <xref rid="bb0100" ref-type="bibr">[20]</xref>. KYN/TRP was calculated as an index of tryptophan breakdown <xref rid="bb0100" ref-type="bibr">[20]</xref>. Serum neopterin concentrations were measured by commercially available enzyme-linked immunosorbent assay (BRAHMS Diagnostics, Hennigsdorf, Germany). The 24&#x000a0;h ambulatory blood pressure (BP) was measured as previously described <xref rid="bb0060" ref-type="bibr">[12]</xref>, <xref rid="bb0065" ref-type="bibr">[13]</xref>.</p></sec><sec id="s0030"><label>2.4</label><title>Statistical analysis</title><p>The sample size for this study was based on the primary outcome of 24-h ambulatory systolic BP. We estimated that 100 participants (50 participants/group) would provide 90% power at two-tailed &#x003b1;&#x000a0;=&#x000a0;0.05 to detect a difference of 3&#x000a0;mm&#x000a0;Hg in 24-h systolic BP. Results of the primary outcome of the study (i.e., BP) have been published <xref rid="bb0060" ref-type="bibr">[12]</xref>. Collection of blood samples during the study allowed investigation of the effects of tea on tryptophan and neopterin metabolisms by measuring circulating concentrations of kynurenine, tryptophan and neopterin. Post-hoc analysis of study power indicated that we had more than 80% power to detect a 1.4&#x000a0;nmol/L difference in neopterin and a 0.45&#x000a0;&#x003bc;mol/L difference in kynurenine.</p><p>Descriptive statistics are presented as means&#x000a0;&#x000b1;&#x000a0;SDs. Categorical variables were summarized by number in each category. A two-tailed type-1 error rate of <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 was the level of significance used for all hypothesis testing. At baseline, characteristics of participants in the 2 groups were compared by using the independent-samples t test on transformed data, when appropriate, and the chi-square test for categorical variables. Spearman's rank correlation coefficient was used to explore the degree and direction of associations of neopterin, kynurenine and KYN/TRP with traditional cardiovascular disease risk factors at baseline. Baseline, 3- and 6-month values for outcome measures and between-group differences are presented as least-squares means and 95% CIs. The primary analysis was a modified intent-to-treat analysis with the population defined as participants who were randomly assigned to the study for which there were complete baseline measurements of neopterin, kynurenine and tryptophan (n&#x000a0;=&#x000a0;94). Outcomes were analyzed by using mixed models in SAS software (version 9.3; SAS Institute Inc.). The PROC MIXED command of the SAS program was used to determine the effect of tea compared with the control. Fixed effects in the model included time (baseline, 3 and 6&#x000a0;months; modeled as 3 separate binary indicator variables), treatment group (tea and control), and treatment group&#x000a0;&#x000d7;&#x000a0;time (in which time was modeled as 3 separate binary indicator variables). The overall effect of treatment was established by using the global treatment group&#x000a0;&#x000d7;&#x000a0;time interaction term. Differences between the tea and control were also assessed and reported individually at 3 and 6&#x000a0;months. Pearson's correlation coefficient was used to explore the degree and direction of associations of the change in neopterin, kynurenine and KYN/TRP from baseline to 6&#x000a0;months (6&#x000a0;months&#x02013;baseline) with the change in 4OMGA from baseline to 6&#x000a0;months and the change in blood pressure from baseline to 6&#x000a0;months.</p></sec></sec><sec id="s0035"><label>3</label><title>Results</title><sec id="s0040"><label>3.1</label><title>Descriptive and baseline data</title><p>The study was performed between October 2007 and September 2010. Ninety-four participants had complete neopterin, kynurenine and tryptophan measurements available at baseline (<xref rid="f0005" ref-type="fig">Fig.&#x000a0;1</xref>). Baseline characteristics of the participants are presented in <xref rid="t0005" ref-type="table">Table&#x000a0;1</xref>. Neopterin, kynurenine, tryptophan and KYN/TRP values at baseline, 3&#x000a0;months and 6&#x000a0;months are presented in <xref rid="t0010" ref-type="table">Table&#x000a0;2</xref>.</p><p>At baseline, neopterin was positively associated with kynurenine (r&#x000a0;=&#x000a0;0.22, <italic>p</italic>&#x000a0;=&#x000a0;0.03) and KYN/TRP (r&#x000a0;=&#x000a0;0.37, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). In addition, during the intervention, at both 3 and 6&#x000a0;months significant correlations existed between neopterin and KYN/TRP in the controls (at 3&#x000a0;months: r&#x000a0;=&#x000a0;0.50, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001; at 6&#x000a0;months: r&#x000a0;=&#x000a0;0.48, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001) and in the tea group (at 3&#x000a0;months: r&#x000a0;=&#x000a0;0.51, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001; at 6&#x000a0;months: r&#x000a0;=&#x000a0;0.50, <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). Neopterin concentrations at baseline were positively associated with age (r&#x000a0;=&#x000a0;0.28, <italic>p</italic>&#x000a0;=&#x000a0;0.007), but there existed no other significant relationships. Kynurenine concentrations at baseline were positively associated with age (r&#x000a0;=&#x000a0;0.28, <italic>p</italic>&#x000a0;=&#x000a0;0.007), waist circumference (r&#x000a0;=&#x000a0;0.32, <italic>p</italic>&#x000a0;=&#x000a0;0.002) and fasting glucose (r&#x000a0;=&#x000a0;0.25, <italic>p</italic>&#x000a0;=&#x000a0;0.02). The baseline KYN/TRP ratio was positively associated with age (r&#x000a0;=&#x000a0;0.32, <italic>p</italic>&#x000a0;=&#x000a0;0.002), body mass index (r&#x000a0;=&#x000a0;0.25, <italic>p</italic>&#x000a0;=&#x000a0;0.02), waist circumference (r&#x000a0;=&#x000a0;0.28, <italic>p</italic>&#x000a0;=&#x000a0;0.006) and fasting glucose (r&#x000a0;=&#x000a0;0.21, <italic>p</italic>&#x000a0;=&#x000a0;0.05).</p></sec><sec id="s0055"><label>3.2</label><title>Effects on neopterin, kynurenine and tryptophan metabolisms</title><p>Regular consumption of tea compared to control did not significantly alter neopterin concentrations over the 6&#x000a0;month intervention period (<italic>p</italic>&#x000a0;=&#x000a0;0.13 for global treatment&#x000a0;&#x000d7;&#x000a0;time interaction; <xref rid="f0010" ref-type="fig">Fig.&#x000a0;2</xref>, upper). At 3&#x000a0;months, the difference between groups was 0.7&#x000a0;nmol/L (95% CI: &#x02212;&#x000a0;0.5, 1.9) (<italic>p</italic>&#x000a0;=&#x000a0;0.27); and at 6&#x000a0;months the difference was 1.3&#x000a0;nmol/L (95% CI: 0.1, 2.5) (<italic>p</italic>&#x000a0;=&#x000a0;0.03). Regular consumption of tea compared to control resulted in a significant difference in kynurenine (<italic>p</italic>&#x000a0;=&#x000a0;0.016 for global treatment&#x000a0;&#x000d7;&#x000a0;time interaction; <xref rid="f0010" ref-type="fig">Fig.&#x000a0;2</xref>, middle). At 3&#x000a0;months the difference between groups was 0.28&#x000a0;&#x003bc;mol/L (95% CI: &#x02212;&#x000a0;0.04, 0.60) (<italic>p</italic>&#x000a0;=&#x000a0;0.083); and at 6&#x000a0;months the difference was 0.48&#x000a0;&#x003bc;mol/L (95% CI: 0.16, 0.80) (<italic>p</italic>&#x000a0;=&#x000a0;0.004). Consumption of tea relative to control also resulted in a significant difference in KYN/TRP (<italic>p</italic>&#x000a0;=&#x000a0;0.012 for global treatment&#x000a0;&#x000d7;&#x000a0;time interaction; <xref rid="f0010" ref-type="fig">Fig.&#x000a0;2</xref>, lower). At 3&#x000a0;months the difference between groups was 3.2&#x000a0;&#x003bc;mol/L (95% CI: &#x02212;&#x000a0;1.6, 8.0) (<italic>p</italic>&#x000a0;=&#x000a0;0.18); and at 6&#x000a0;months the difference was 7.5&#x000a0;&#x003bc;mol/L (95% CI: 2.5, 12.5) (<italic>p</italic>&#x000a0;=&#x000a0;0.003). Adjustment for age, body mass index, waist circumference and fasting glucose concentrations did not alter the observed effects on kynurenine or KYN/TRP (data not presented). Tryptophan concentrations over the 6&#x000a0;month intervention period were not altered (<italic>p</italic>&#x000a0;=&#x000a0;0.85).</p><p>The change in 4OMGA (biomarker of tea intake and polyphenol exposure) from baseline to 6&#x000a0;months (6&#x000a0;months&#x02013;baseline) was positively correlated with change (6&#x000a0;months&#x02013;baseline) in kynurenine (r&#x000a0;=&#x000a0;0.31, <italic>p</italic>&#x000a0;=&#x000a0;0.008) and KYN/TRP (r&#x000a0;=&#x000a0;0.30, <italic>p</italic>&#x000a0;=&#x000a0;0.01) but not neopterin (r&#x000a0;=&#x000a0;0.13, <italic>p</italic>&#x000a0;=&#x000a0;0.28). In addition, the change in 24-h systolic and diastolic blood pressure (6&#x000a0;months&#x02013;baseline) was negatively correlated with the change (6&#x000a0;months&#x02013;baseline) in neopterin (systolic: r&#x000a0;=&#x000a0;&#x02212;&#x000a0;0.26, <italic>p</italic>&#x000a0;=&#x000a0;0.03; diastolic: r&#x000a0;=&#x000a0;&#x02212;&#x000a0;0.31, <italic>p</italic>&#x000a0;=&#x000a0;0.006), kynurenine (systolic r&#x000a0;=&#x000a0;&#x02212;&#x000a0;0.20, <italic>p</italic>&#x000a0;=&#x000a0;0.08; diastolic: r&#x000a0;=&#x000a0;&#x02212;&#x000a0;0.21, <italic>p</italic>&#x000a0;=&#x000a0;0.06) and KYN/TRP (systolic: r&#x000a0;=&#x000a0;&#x02212;&#x000a0;0.26, <italic>p</italic>&#x000a0;=&#x000a0;0.02; diastolic r&#x000a0;=&#x000a0;&#x02212;&#x000a0;0.23, <italic>p</italic>&#x000a0;=&#x000a0;0.04).</p></sec></sec><sec id="s0045"><label>4</label><title>Discussion</title><p>Our study revealed that black tea consumption in comparison to a caffeine-matched control beverage may increase serum concentrations of immunobiochemical markers of tryptophan metabolism. Both kynurenine and KYN/TRP were significantly increased with tea over the 6&#x000a0;month intervention, with the largest increases observed at the 6&#x000a0;month time point with tea compared to control. Although a similar trend for neopterin was found and the difference in changes from baseline at 6&#x000a0;months was significant, there was no overall significant difference between group changes over the 6&#x000a0;month intervention.</p><p>Black and green tea extracts and related polyphenols were shown to exert suppressive effects on neopterin and cytokine production and on KYN/TRP <italic>in vitro</italic>
<xref rid="bb0070" ref-type="bibr">[14]</xref>, <xref rid="bb0075" ref-type="bibr">[15]</xref>, <xref rid="bb0080" ref-type="bibr">[16]</xref>. Thus, the increase of kynurenine concentrations in the tea group is unexpected at first glance, because a cardioprotective activity of black tea is considered in part to be due to anti-inflammatory and immunosuppressive properties&#x000a0;<xref rid="bb0105" ref-type="bibr">[21]</xref>, <xref rid="bb0110" ref-type="bibr">[22]</xref>, <xref rid="bb0115" ref-type="bibr">[23]</xref>. However, in the <italic>in vitro</italic> studies, the immunosuppressive properties were observed in PBMC that were pre-stimulated with mitogens such as phytohemagglutinin or concanavalin A. In contrast, there was a stimulatory effect of extracts on resting PBMC <xref rid="bb0075" ref-type="bibr">[15]</xref>, <xref rid="bb0080" ref-type="bibr">[16]</xref>. Thus, the findings of the present study that black tea consumption may induce neopterin formation and kynurenine production due to accelerated tryptophan breakdown are in line with the observations derived from in vitro studies using resting PBMC. This may be more representative of what occurs in healthy individuals, while the suppression of stimulated PBMC may reflect processes that occur in individuals with an activated immune system. Interestingly, both anti- and pro-oxidant properties have been reported for green tea catechins <xref rid="bb0060" ref-type="bibr">[12]</xref>, <xref rid="bb0120" ref-type="bibr">[24]</xref>, <xref rid="bb0125" ref-type="bibr">[25]</xref>, <xref rid="bb0130" ref-type="bibr">[26]</xref>. Induction of ROS due to superoxide formation by catechin in the presence of oxygen and transition metals is an important property for its bioactivity as phytotoxin <xref rid="bb0130" ref-type="bibr">[26]</xref>, but also for its chemopreventive effects <xref rid="bb0135" ref-type="bibr">[27]</xref>. Thus, these bidirectional effects could help to explain why black tea is associated with reduced risk of CVD. This may involve both enhancing activation status of immunocompetent cells leading to increased immune surveillance and inhibiting low grade inflammation.</p><p>The correlations found between the kynurenine and KYN/TRP concentrations and the concentrations of immune activation marker neopterin suggest that they are associated with increased immune activation and inflammation. Thus, the observed association between kynurenine metabolism (KYN/TRP) and neopterin concentrations throughout the study in both groups suggests an involvement of enzyme indoleamine 2,3-dioxygenase (IDO) rather than liver enzyme tryptophan 2,3-dioxygenase (TDO) in the alterations of kynurenine concentrations. TDO is primarily controlled by tryptophan concentrations but independent from immunological stimuli. However, the association between neopterin and kynurenine levels indicates an induction of pro-inflammatory cytokine cascades in study participants to be responsible for the induction of IDO and the increase of kynurenine. We speculate that the influence of black tea on kynurenine concentrations was due to the induction of pro-inflammatory cytokines like IFN-&#x003b3;. This may support protection of the human organism from infection and even malignant development in an antiproliferative milieu, which is achieved by the induction of IFN-&#x003b3;-dependent effector pathways. It is possible that the situation might be different in patients that are already suffering from inflammatory diseases and thus heightened oxidative stress. Our findings in healthy individuals may not be extrapolated to those suffering from CVD, infections or malignant diseases.</p><p>The observed increase of kynurenine and KYN/TRP concentrations might also relate to the influence of black tea to lower blood pressure and its benefit for cardiovascular health <xref rid="bb0105" ref-type="bibr">[21]</xref>, <xref rid="bb0110" ref-type="bibr">[22]</xref>, <xref rid="bb0115" ref-type="bibr">[23]</xref>, <xref rid="bb0135" ref-type="bibr">[27]</xref>, <xref rid="bb0140" ref-type="bibr">[28]</xref>, <xref rid="bb0145" ref-type="bibr">[29]</xref>, <xref rid="bb0150" ref-type="bibr">[30]</xref>. In rats administration of kynurenine was demonstrated to beneficially influence blood pressure. In the current study we observed a negative correlation between the change in kynurenine and the change in blood pressure from baseline to 6&#x000a0;months. Thus, the increase of kynurenine levels in the tea group in our study may be linked to the blood pressure lowering during black tea consumption, which was described earlier <xref rid="bb0095" ref-type="bibr">[19]</xref>, <xref rid="bb0145" ref-type="bibr">[29]</xref>.</p><p>Of note, at baseline, significant associations were found for kynurenine with parameters such as waist circumference and fasting glucose, as well as for KYN/TRP with age, body mass index, waist circumference and fasting glucose. Given the close crosstalk between metabolism and immune response, also these associations indicate an individual's immune status. An association of neopterin levels with age and immune status has been documented earlier <xref rid="bb0155" ref-type="bibr">[31]</xref></p><p>In conclusion, our study shows that black tea consumption is associated with an increased kynurenine production in individuals with no major illnesses and having normal to mildly elevated systolic blood pressure. It may partly relate to the positive influence of black tea on blood pressure in our study participants, and it is suggested to relate to activation of IDO. In turn, activated IDO could contribute to slowing down of immune activation and inflammation.</p></sec></body><back><ref-list><title>References</title><ref id="bb0005"><label>1</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>G.K.</given-names></name></person-group><article-title>Inflammation, atherosclerosis, and coronary artery disease</article-title><source>N. Engl. J. Med.</source><volume>352</volume><year>2005</year><fpage>1685</fpage><lpage>1695</lpage><pub-id pub-id-type="pmid">15843671</pub-id></element-citation></ref><ref id="bb0010"><label>2</label><element-citation publication-type="journal" id="rf0010"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P.</given-names></name><name><surname>Crea</surname><given-names>F.</given-names></name></person-group><article-title>Clinical implications of inflammation for cardiovascular primary prevention</article-title><source>Eur. Heart J.</source><volume>31</volume><year>2010</year><fpage>777</fpage><lpage>783</lpage><pub-id pub-id-type="pmid">20185554</pub-id></element-citation></ref><ref id="bb0015"><label>3</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name><surname>Pertovaara</surname><given-names>M.</given-names></name><name><surname>Raitala</surname><given-names>A.</given-names></name><name><surname>Juonala</surname><given-names>M.</given-names></name><name><surname>Lehtim&#x000e4;ki</surname><given-names>T.</given-names></name><name><surname>Huhtala</surname><given-names>H.</given-names></name><name><surname>Oja</surname><given-names>S.S.</given-names></name><name><surname>Jokinen</surname><given-names>E.</given-names></name><name><surname>Viikari</surname><given-names>J.S.</given-names></name><name><surname>Raitakari</surname><given-names>O.T.</given-names></name><name><surname>Hurme</surname><given-names>M.</given-names></name></person-group><article-title>Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study</article-title><source>Clin. Exp. Immunol.</source><volume>148</volume><year>2007</year><fpage>106</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">17349013</pub-id></element-citation></ref><ref id="bb0020"><label>4</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>E.R.</given-names></name><name><surname>Midttun</surname><given-names>&#x000d8;.</given-names></name><name><surname>Ueland</surname><given-names>P.M.</given-names></name><name><surname>Schartum-Hansen</surname><given-names>H.</given-names></name><name><surname>Seifert</surname><given-names>R.</given-names></name><name><surname>Igland</surname><given-names>J.</given-names></name><name><surname>Nordrehaug</surname><given-names>J.E.</given-names></name><name><surname>Ebbing</surname><given-names>M.</given-names></name><name><surname>Svingen</surname><given-names>G.</given-names></name><name><surname>Bleie</surname><given-names>&#x000d8;.</given-names></name><name><surname>Berge</surname><given-names>R.</given-names></name><name><surname>Nyg&#x000e5;rd</surname><given-names>O.</given-names></name></person-group><article-title>Systemic markers of interferon-&#x003b3;-mediated immune activation and long-term prognosis in patients with stable coronary artery disease</article-title><source>Arterioscler. Thromb. Vasc. Biol.</source><volume>31</volume><year>2011</year><fpage>698</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">21183733</pub-id></element-citation></ref><ref id="bb0025"><label>5</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name><surname>Di Mascio</surname><given-names>P.</given-names></name><name><surname>Kaiser</surname><given-names>S.</given-names></name><name><surname>Sies</surname><given-names>H.</given-names></name></person-group><article-title>Lycopene as the most efficient biological carotenoid singlet oxygen quencher</article-title><source>Arch. Biochem. Biophys.</source><volume>274</volume><year>1989</year><fpage>532</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">2802626</pub-id></element-citation></ref><ref id="bb0030"><label>6</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name><surname>Sies</surname><given-names>H.</given-names></name><name><surname>Stahl</surname><given-names>H.W.</given-names></name><name><surname>Sundquist</surname><given-names>A.R.</given-names></name></person-group><article-title>Antioxidant functions of vitamins. Vitamins E and C beta-carotene and other carotenoids</article-title><source>Ann. NY Acad. Sci.</source><volume>669</volume><year>1992</year><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">1444060</pub-id></element-citation></ref><ref id="bb0035"><label>7</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name><surname>Murr</surname><given-names>C.</given-names></name><name><surname>Winklhofer-Roob</surname><given-names>B.M.</given-names></name><name><surname>Schroecksnadel</surname><given-names>K.</given-names></name><name><surname>Maritschnegg</surname><given-names>M.</given-names></name><name><surname>Mangge</surname><given-names>H.</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>B.O.</given-names></name><name><surname>Winkelmann</surname><given-names>B.R.</given-names></name><name><surname>M&#x000e4;rz</surname><given-names>W.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title>Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease</article-title><source>Atherosclerosis</source><volume>202</volume><year>2009</year><fpage>543</fpage><lpage>549</lpage><pub-id pub-id-type="pmid">18556000</pub-id></element-citation></ref><ref id="bb0040"><label>8</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B.</given-names></name></person-group><article-title>Antioxidant defence mechanisms: from the beginning to the end (of the beginning)</article-title><source>Free Radic. Res.</source><volume>31</volume><year>1999</year><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">10517532</pub-id></element-citation></ref><ref id="bb0045"><label>9</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name><surname>Kaliora</surname><given-names>A.C.</given-names></name><name><surname>Dedoussis</surname><given-names>G.V.</given-names></name><name><surname>Schmidt</surname><given-names>H.</given-names></name></person-group><article-title>Dietary antioxidants in preventing atherogenesis</article-title><source>Atherosclerosis</source><volume>187</volume><year>2006</year><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">16313912</pub-id></element-citation></ref><ref id="bb0050"><label>10</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name><surname>Estruch</surname><given-names>R.</given-names></name><name><surname>Ros</surname><given-names>R.</given-names></name><name><surname>Salas-Salvad&#x000f3;</surname><given-names>J.</given-names></name><name><surname>Covas</surname><given-names>M.I.</given-names></name><name><surname>Corella</surname><given-names>D.</given-names></name><name><surname>Ar&#x000f3;s</surname><given-names>F.</given-names></name><name><surname>G&#x000f3;mez-Gracia</surname><given-names>E.</given-names></name><name><surname>Ruiz-Guti&#x000e9;rrez</surname><given-names>V.</given-names></name><name><surname>Fiol</surname><given-names>M.</given-names></name><name><surname>Lapetra</surname><given-names>J.</given-names></name><name><surname>Lamuela-Raventos</surname><given-names>R.M.</given-names></name><name><surname>Serra-Majem</surname><given-names>L.</given-names></name><name><surname>Pint&#x000f3;</surname><given-names>X.</given-names></name><name><surname>Basora</surname><given-names>J.</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>M.A.</given-names></name><name><surname>Sorl&#x000ed;</surname><given-names>J.V.</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>J.A.</given-names></name><name><surname>Mart&#x000ed;nez-Gonz&#x000e1;lez</surname><given-names>M.A.</given-names></name><collab>PREDIMED Study Investigators</collab></person-group><article-title>Primary prevention of cardiovascular disease with a Mediterranean diet</article-title><source>N. Engl. J. Med.</source><volume>368</volume><year>2013</year><fpage>1279</fpage><lpage>1290</lpage><pub-id pub-id-type="pmid">23432189</pub-id></element-citation></ref><ref id="bb0055"><label>11</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name><surname>Schwingshackl</surname><given-names>L.</given-names></name><name><surname>Hoffmann</surname><given-names>G.</given-names></name></person-group><article-title>Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials</article-title><source>Nutr. Metab. Cardiovasc. Dis.</source><volume>24</volume><year>2014</year><fpage>929</fpage><lpage>939</lpage><pub-id pub-id-type="pmid">24787907</pub-id></element-citation></ref><ref id="bb0060"><label>12</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>J.M.</given-names></name><name><surname>Puddey</surname><given-names>I.B.</given-names></name><name><surname>Woodman</surname><given-names>R.J.</given-names></name><name><surname>Mulder</surname><given-names>T.P.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name><name><surname>Scott</surname><given-names>K.</given-names></name><name><surname>Croft</surname><given-names>K.D.</given-names></name></person-group><article-title>Effects of black tea on blood pressure: a randomized controlled trial</article-title><source>Arch. Intern. Med.</source><volume>172</volume><year>2012</year><fpage>186</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">22271130</pub-id></element-citation></ref><ref id="bb0065"><label>13</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>J.M.</given-names></name><name><surname>Woodman</surname><given-names>R.J.</given-names></name><name><surname>Puddey</surname><given-names>I.B.</given-names></name><name><surname>Mulder</surname><given-names>T.P.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name><name><surname>Croft</surname><given-names>K.D.</given-names></name></person-group><article-title>Short-term effects of polyphenol-rich black tea on blood pressure in men and women</article-title><source>Food Funct.</source><volume>4</volume><year>2013</year><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">23038021</pub-id></element-citation></ref><ref id="bb0070"><label>14</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name><surname>Jenny</surname><given-names>M.</given-names></name><name><surname>Klieber</surname><given-names>M.</given-names></name><name><surname>Zaknun</surname><given-names>D.</given-names></name><name><surname>Schroecksnadel</surname><given-names>S.</given-names></name><name><surname>Kurz</surname><given-names>K.</given-names></name><name><surname>Ledochowski</surname><given-names>M.</given-names></name><name><surname>Schennach</surname><given-names>H.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title><italic>In vitro</italic> testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors</article-title><source>Inflamm. Res.</source><volume>60</volume><year>2011</year><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">20740299</pub-id></element-citation></ref><ref id="bb0075"><label>15</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name><surname>Wirleitner</surname><given-names>B.</given-names></name><name><surname>Schroecksnadel</surname><given-names>K.</given-names></name><name><surname>Winkler</surname><given-names>C.</given-names></name><name><surname>Schennach</surname><given-names>H.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title>Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro</article-title><source>Immunol. Lett.</source><volume>100</volume><year>2005</year><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">16154495</pub-id></element-citation></ref><ref id="bb0080"><label>16</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name><surname>Zvetkova</surname><given-names>E.</given-names></name><name><surname>Wirleitner</surname><given-names>B.</given-names></name><name><surname>Tram</surname><given-names>N.T.</given-names></name><name><surname>Schennach</surname><given-names>H.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title>Aqueous extracts of <italic>Crinum latifolium</italic> (L.) and <italic>Camellia sinensis</italic> show immunomodulatory properties in human peripheral blood mononuclear cells</article-title><source>Int. Immunopharmacol.</source><volume>1</volume><year>2011</year><fpage>2143</fpage><lpage>2150</lpage><pub-id pub-id-type="pmid">11710543</pub-id></element-citation></ref><ref id="bb0085"><label>17</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name><surname>Neurauter</surname><given-names>G.</given-names></name><name><surname>Wirleitner</surname><given-names>B.</given-names></name><name><surname>Schroecksnadel</surname><given-names>K.</given-names></name><name><surname>Schennach</surname><given-names>H.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title>Wine and grape juice modulate interferon-&#x003b3;-induced neopterin production and tryptophan degradation in human PBMC</article-title><source>Pteridines</source><volume>15</volume><year>2004</year><fpage>1</fpage><lpage>9</lpage></element-citation></ref><ref id="bb0090"><label>18</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name><surname>Gostner</surname><given-names>J.M.</given-names></name><name><surname>Schroecksnadel</surname><given-names>S.</given-names></name><name><surname>Jenny</surname><given-names>M.</given-names></name><name><surname>Klein</surname><given-names>A.</given-names></name><name><surname>Ueberall</surname><given-names>F.</given-names></name><name><surname>Schennach</surname><given-names>H.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title>Coffee extracts suppress tryptophan breakdown in mitogen-stimulated peripheral blood mononuclear cells</article-title><source>J. Am. Coll. Nutr.</source><year>2014</year><comment>(in press)</comment></element-citation></ref><ref id="bb0095"><label>19</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>McKenzie</surname><given-names>G.</given-names></name><name><surname>Witting</surname><given-names>P.K.</given-names></name><name><surname>Stasch</surname><given-names>J.P.</given-names></name><name><surname>Hahn</surname><given-names>M.</given-names></name><name><surname>Changsirivathanathamrong</surname><given-names>D.</given-names></name><name><surname>Wu</surname><given-names>B.J.</given-names></name><name><surname>Ball</surname><given-names>H.J.</given-names></name><name><surname>Thomas</surname><given-names>S.R.</given-names></name><name><surname>Kapoor</surname><given-names>V.</given-names></name><name><surname>Celermajer</surname><given-names>D.S.</given-names></name><name><surname>Mellor</surname><given-names>A.L.</given-names></name><name><surname>Keaney Jr.</surname><given-names>J.F.</given-names></name><name><surname>Hunt</surname><given-names>N.H.</given-names></name><name><surname>Stocker</surname><given-names>R.</given-names></name></person-group><article-title>Kynurenine is an endothelium-derived relaxing factor produced during inflammation</article-title><source>Nat. Med.</source><volume>16</volume><year>2010</year><fpage>279</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">20190767</pub-id></element-citation></ref><ref id="bb0100"><label>20</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name><surname>Widner</surname><given-names>B.</given-names></name><name><surname>Werner</surname><given-names>E.R.</given-names></name><name><surname>Schennach</surname><given-names>H.</given-names></name><name><surname>Wachter</surname><given-names>H.</given-names></name><name><surname>Fuchs</surname><given-names>D.</given-names></name></person-group><article-title>Simultaneous measurement of serum tryptophan and kynurenine by HPLC</article-title><source>Clin. Chem.</source><volume>43</volume><year>1997</year><fpage>2424</fpage><lpage>2426</lpage><pub-id pub-id-type="pmid">9439467</pub-id></element-citation></ref><ref id="bb0105"><label>21</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name><surname>Nantz</surname><given-names>M.P.</given-names></name><name><surname>Rowe</surname><given-names>C.A.</given-names></name><name><surname>Bukowski</surname><given-names>J.F.</given-names></name><name><surname>Percival</surname><given-names>S.S.</given-names></name></person-group><article-title>Standardized capsule of <italic>Camellia sinensis</italic> lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study</article-title><source>Nutrition</source><volume>25</volume><year>2009</year><fpage>147</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">18848434</pub-id></element-citation></ref><ref id="bb0110"><label>22</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name><surname>Hodgson</surname><given-names>J.M.</given-names></name><name><surname>Croft</surname><given-names>K.D.</given-names></name></person-group><article-title>Tea flavonoids and cardiovascular health</article-title><source>Mol. Aspects Med.</source><volume>31</volume><year>2010</year><fpage>495</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">20837049</pub-id></element-citation></ref><ref id="bb0115"><label>23</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.M.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>Y.S.</given-names></name><name><surname>Gong</surname><given-names>Q.Y.</given-names></name><name><surname>Wang</surname><given-names>Q.M.</given-names></name><name><surname>Yan</surname><given-names>J.J.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>L.S.</given-names></name></person-group><article-title>Black and green tea consumption and the risk of coronary artery disease: a meta-analysis</article-title><source>Am. J. Clin. Nutr.</source><volume>93</volume><year>2011</year><fpage>506</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">21248184</pub-id></element-citation></ref><ref id="bb0120"><label>24</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name><surname>Colon</surname><given-names>M.</given-names></name><name><surname>Nerin</surname><given-names>C.</given-names></name></person-group><article-title>Role of catechins in the antioxidant capacity of an active film containing green tea, green coffee, and grapefruit extracts</article-title><source>J. Agric. Food Chem.</source><volume>60</volume><year>2012</year><fpage>9842</fpage><lpage>9849</lpage><pub-id pub-id-type="pmid">22973940</pub-id></element-citation></ref><ref id="bb0125"><label>25</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name><surname>Henning</surname><given-names>S.M.</given-names></name><name><surname>Fajardo-Lira</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>H.W.</given-names></name><name><surname>Youssefian</surname><given-names>A.A.</given-names></name><name><surname>Go</surname><given-names>V.L.</given-names></name><name><surname>Heber</surname><given-names>D.</given-names></name></person-group><article-title>Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity</article-title><source>Nutr. Cancer</source><volume>45</volume><year>2003</year><fpage>226</fpage><lpage>235</lpage><pub-id pub-id-type="pmid">12881018</pub-id></element-citation></ref><ref id="bb0130"><label>26</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>S.</given-names></name><name><surname>Bais</surname><given-names>H.P.</given-names></name><name><surname>Biedrzycki</surname><given-names>M.L.</given-names></name><name><surname>Venkatachalam</surname><given-names>L.</given-names></name></person-group><article-title>Catechin is a phytototoxin and a pro-oxidant secreted from the roots of <italic>Centaurea stoebe</italic></article-title><source>Plant Signal. Behav.</source><volume>5</volume><year>2010</year><fpage>1088</fpage><lpage>1098</lpage><pub-id pub-id-type="pmid">20505358</pub-id></element-citation></ref><ref id="bb0135"><label>27</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>J.D.</given-names></name><name><surname>Elias</surname><given-names>R.J.</given-names></name></person-group><article-title>The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention</article-title><source>Arch. Biochem. Biophys.</source><volume>501</volume><year>2010</year><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">20558130</pub-id></element-citation></ref><ref id="bb0140"><label>28</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name><surname>Toda</surname><given-names>S.</given-names></name></person-group><article-title>Polyphenol content and antioxidant effects in herb teas</article-title><source>Chin. Med.</source><volume>2</volume><year>2011</year><fpage>29</fpage><lpage>31</lpage></element-citation></ref><ref id="bb0145"><label>29</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name><surname>Grassi</surname><given-names>D.</given-names></name><name><surname>Mulder</surname><given-names>T.P.</given-names></name><name><surname>Draijer</surname><given-names>R.</given-names></name><name><surname>Desideri</surname><given-names>G.</given-names></name><name><surname>Molhuizen</surname><given-names>H.O.</given-names></name><name><surname>Ferri</surname><given-names>C.</given-names></name></person-group><article-title>Black tea consumption dose-dependently improves flow-mediated dilation in healthy males</article-title><source>J. Hypertens.</source><volume>27</volume><year>2009</year><fpage>774</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">19516176</pub-id></element-citation></ref><ref id="bb0150"><label>30</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name><surname>Ras</surname><given-names>R.T.</given-names></name><name><surname>Zock</surname><given-names>P.L.</given-names></name><name><surname>Draijer</surname><given-names>R.</given-names></name></person-group><article-title>Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis</article-title><source>PLoS ONE</source><volume>6</volume><year>2011</year><fpage>e16974</fpage><pub-id pub-id-type="pmid">21394199</pub-id></element-citation></ref><ref id="bb0155"><label>31</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name><surname>Reibnegger</surname><given-names>G.</given-names></name><name><surname>Huber</surname><given-names>L.A.</given-names></name><name><surname>J&#x000fc;rgens</surname><given-names>G.</given-names></name><name><surname>Sch&#x000f6;nitzer</surname><given-names>D.</given-names></name><name><surname>Werner</surname><given-names>E.R.</given-names></name><name><surname>Wachter</surname><given-names>H.</given-names></name><name><surname>Wick</surname><given-names>G.</given-names></name><name><surname>Traill</surname><given-names>K.N.</given-names></name></person-group><article-title>Approach to define &#x0201c;normal aging&#x0201d; in man. Immune function, serum lipids, lipoproteins and neopterin levels</article-title><source>Mech. Ageing Dev.</source><volume>46</volume><year>1988</year><fpage>67</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">3226163</pub-id></element-citation></ref></ref-list><ack id="ac0005"><title>Acknowledgments</title><p>The study was supported by the <funding-source id="gts0005">National Health and Medical Research Council of Australia</funding-source> (grant 513744) and <funding-source id="gts0010">Unilever Research and Development</funding-source>. In addition, test products were supplied by Unilever Research and Development. JMH was supported by a National Health and Medical Research Council of Australia Senior Research Fellowship.</p></ack><fn-group><fn id="d32e446"><label>&#x02606;</label><p>This trial was registered at the Australian New Zealand Clinical Trials Registry as ACTR12607000543482.</p></fn></fn-group></back><floats-group><fig id="f0005"><label>Fig.&#x000a0;1</label><caption><p>Participants at each stage of the trial.</p></caption><graphic xlink:href="gr1"/></fig><fig id="f0010"><label>Fig.&#x000a0;2</label><caption><p>Serum concentrations (mean&#x000a0;&#x000b1;&#x000a0;SD) of neopterin (upper), kynurenine (middle) and kynurenine to tryptophan ratio (KYN/TRP) (lower) in individuals exposed to tea during 6&#x000a0;months (<italic>p</italic>-values for treatment by time interactions). Participants consumed 3&#x000a0;cups/day of either powdered black tea solids (red lines) or a flavonoid-free caffeine-matched beverage (blue lines).</p></caption><graphic xlink:href="gr2"/></fig><table-wrap id="t0005" position="float"><label>Table&#x000a0;1</label><caption><p>Baseline characteristics of the participants in the control and tea groups.<xref rid="tf0025" ref-type="table-fn">a</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Control (n&#x000a0;=&#x000a0;49)</th><th align="left">Tea (n&#x000a0;=&#x000a0;45)</th></tr></thead><tbody><tr><td align="left">Gender (M/F)</td><td align="left">18/31</td><td align="left">15/30</td></tr><tr><td align="left">Age (year)</td><td align="left">56.3 (10.6)<xref rid="tf0030" ref-type="table-fn">b</xref></td><td align="left">57.1 (10.8)</td></tr><tr><td align="left">Body mass index (kg/m<sup>2</sup>)</td><td align="left">25.2 (3.3)</td><td align="left">24.8 (3.6)</td></tr><tr><td align="left">Waist circumference (cm)</td><td align="left">82 (12)</td><td align="left">82 (11)</td></tr><tr><td align="left">Total cholesterol (mmol/L)</td><td align="left">5.2 (1.0)</td><td align="left">5.1 (0.8)</td></tr><tr><td align="left">Glucose (mmol/L)</td><td align="left">5.1 (0.5)</td><td align="left">5.2 (0.8)</td></tr><tr><td align="left">Office systolic blood pressure (mm Hg)</td><td align="left">119 (14)</td><td align="left">122 (14)</td></tr><tr><td align="left">Office diastolic blood pressure (mm Hg)</td><td align="left">70 (7)</td><td align="left">69 (7)</td></tr></tbody></table><table-wrap-foot><fn id="tf0025"><label>a</label><p>Intent-to-treat population included 94 participants; characteristics were not different between groups at baseline (<italic>p</italic>&#x000a0;&#x0003e;&#x000a0;0.05 for between-group differences analyzed using independent samples t-test and the chi-square test for categorical variables).</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0030"><label>b</label><p>Mean (SD) for all such values.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t0010" position="float"><label>Table&#x000a0;2</label><caption><p>Neopterin, kynurenine, tryptophan and KYN/TRP values at baseline, 3&#x000a0;months and 6&#x000a0;months.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Control (n&#x000a0;=&#x000a0;49)</th><th align="left">Tea (n&#x000a0;=&#x000a0;45)</th><th align="left">Difference (95% CI)</th><th align="left"><italic>p</italic>-Value</th></tr></thead><tbody><tr><td align="left">Neopterin (nmol/L)</td><td/><td/><td/><td/></tr><tr><td align="left">&#x000a0;Baseline</td><td align="char">6.9 (3.6)<xref rid="tf0020" ref-type="table-fn">b</xref></td><td align="char">5.5 (1.7)</td><td/><td/></tr><tr><td align="left">&#x000a0;3&#x000a0;months</td><td align="char">6.4 (2.7)</td><td align="char">5.6 (1.9)</td><td align="char">0.7 (&#x02212;&#x000a0;0.5, 1.9)<xref rid="tf0015" ref-type="table-fn">a</xref></td><td align="char">0.27</td></tr><tr><td align="left">&#x000a0;6&#x000a0;months</td><td align="char">5.8 (2.0)</td><td align="char">5.7 (3.3)</td><td align="char">1.3 (0.1, 2.5)</td><td align="char">0.03</td></tr><tr><td align="left">&#x000a0;Global treatment&#x000a0;&#x000d7;&#x000a0;time interaction</td><td/><td/><td/><td align="char">0.13</td></tr><tr><td align="left">Tryptophan (&#x003bc;mol/L)</td><td/><td/><td/><td/></tr><tr><td align="left">&#x000a0;Baseline</td><td align="char">68 (11)</td><td align="char">70 (10)</td><td/><td/></tr><tr><td align="left">&#x000a0;3&#x000a0;months</td><td align="char">68 (11)</td><td align="char">71 (12)</td><td align="char">1.2 (&#x02212;&#x000a0;1.4, 5.6)</td><td align="char">0.57</td></tr><tr><td align="left">&#x000a0;6&#x000a0;months</td><td align="char">69 (13)</td><td align="char">71 (11)</td><td align="char">0.6 (&#x02212;&#x000a0;3.8, 5.0)</td><td align="char">0.79</td></tr><tr><td align="left">&#x000a0;Global treatment&#x000a0;&#x000d7;&#x000a0;time interaction</td><td/><td/><td/><td align="char">0.85</td></tr><tr><td align="left">Kynurenine (&#x003bc;mol/L)</td><td/><td/><td/><td/></tr><tr><td align="left">&#x000a0;Baseline</td><td align="char">3.2 (0.9)</td><td align="char">2.9 (0.7)</td><td/><td/></tr><tr><td align="left">&#x000a0;3&#x000a0;months</td><td align="char">3.1 (0.9)</td><td align="char">3.1 (0.7)</td><td align="char">0.28 (&#x02212;&#x000a0;0.04, 0.60)</td><td align="char">0.083</td></tr><tr><td align="left">&#x000a0;6&#x000a0;months</td><td align="char">3.1 (1.0)</td><td align="char">3.4 (0.8)</td><td align="char">0.48 (0.16, 0.80)</td><td align="char">0.004</td></tr><tr><td align="left">&#x000a0;Global treatment&#x000a0;&#x000d7;&#x000a0;time interaction</td><td/><td/><td/><td align="char">0.016</td></tr><tr><td align="left">KYN/TRP (&#x000d7;&#x000a0;1000)</td><td/><td/><td/><td/></tr><tr><td align="left">&#x000a0;Baseline</td><td align="char">47 (12)</td><td align="char">42 (9)</td><td/><td/></tr><tr><td align="left">&#x000a0;3&#x000a0;months</td><td align="char">46 (12)</td><td align="char">44 (9)</td><td align="char">3.2 (&#x02212;&#x000a0;1.6, 8.0)</td><td align="char">0.18</td></tr><tr><td align="left">&#x000a0;6&#x000a0;months</td><td align="char">45 (12)</td><td align="char">49 (14)</td><td align="char">7.5 (2.5, 12.5)</td><td align="char">0.003</td></tr><tr><td align="left">&#x000a0;Global treatment&#x000a0;&#x000d7;&#x000a0;time interaction</td><td/><td/><td/><td align="char">0.012</td></tr></tbody></table><table-wrap-foot><fn id="tf0015"><label>a</label><p>Least squares mean difference.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0020"><label>b</label><p>Observed mean values and SD in brackets.</p></fn></table-wrap-foot></table-wrap></floats-group></article>